GlassScriptPhysician profile
Sean E Mazloom
NPI 1518256932
$3,049.89
in general payments reported to CMS, 2019-2025
33 companies · $467 in 2025
The $467 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $159 · 2021: $75.71 · 2022: $190 · 2023: $422 · 2024: $784 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,672.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $424.80 | 2020-2025 | Novachor, Puraply, Cygnus Dual |
| Revance Therapeutics, INC. | $336.53 | 2024-2025 | Daxxify |
| Abbvie INC. | $284.29 | 2019-2023 | |
| Almirall LLC | $251.34 | 2019 | |
| Merz North America, INC. | $208.50 | 2019-2023 | Xeomin |
| Epsfl, LLC | $185.47 | 2023 | |
| Sensus Healthcare, INC. | $184.53 | 2024 | |
| Biofrontera INC. | $176.16 | 2022-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Galderma Laboratories, L.P. | $98.77 | 2019-2025 | Nemluvio |
| Janssen Biotech, INC. | $80.37 | 2019-2020 | |
| Amgen INC. | $73.78 | 2025 | Otezla |
| Sun Pharmaceutical Industries INC. | $66.52 | 2019-2021 | |
| Lilly USA, LLC | $62.90 | 2019-2020 | |
| Celgene Corporation | $62.49 | 2019 | |
| Dermavant Sciences, INC. | $58.28 | 2024 | Vtama |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $55.61 | 2019 | |
| Pfizer INC. | $47.34 | 2019-2023 | |
| Smith+Nephew, INC. | $45.06 | 2025 | Oasis, Collagenase Santyl |
| Boston Scientific Corporation | $44.60 | 2021-2024 | Varithena Administration Pack |
| Convatec INC. | $33.22 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.30 | 2019 | |
| Organon LLC | $31.77 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $27.46 | 2019 | |
| Allergan, INC. | $23.56 | 2022 | |
| Next Science LLC | $21.83 | 2023 | Surgx, Xperience, Blastx |
| Mayne Pharma Commercial LLC | $20.60 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.58 | 2022 | |
| Encore Dermatology INC. | $19.36 | 2019 | |
| Kerecis Limited | $17.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $17.27 | 2025 | |
| Ge Healthcare | $12.94 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $12.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mazloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.